LOFRIC DILACATH 40618

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2013-06-14 for LOFRIC DILACATH 40618 manufactured by Wellspect Healthcare.

Event Text Entries

[3554885] The customer thinks the coating is rough and he had a bleeding after catheterization.
Patient Sequence No: 1, Text Type: D, B5


[10746600] This submission is being made after an acquisition and internal audit of wellspect healthcare. Samples returned have been analyzed and no defects or deviations could be found. Based upon the product testing, this complaint could not be confirmed as reported.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3009632672-2013-00022
MDR Report Key3181413
Report Source05
Date Received2013-06-14
Date of Report2011-09-08
Date Mfgr Received2011-09-08
Date Added to Maude2013-06-24
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional0
Initial Report to FDA0
Report to FDA0
Event Location0
Manufacturer ContactMARIE SKOGLUND
Manufacturer StreetAMINOGATAN 1 P.O. BOX 14
Manufacturer CityMOLNDAL SE-43121
Manufacturer CountrySW
Manufacturer PostalSE-43121
Manufacturer Phone13764000
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameLOFRIC DILACATH
Generic NameURETHRAL DILATOR, FBX
Product CodeFBX
Date Received2013-06-14
Model Number40618
Catalog Number40618
Lot Number86793
Device AvailabilityY
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerWELLSPECT HEALTHCARE
Manufacturer AddressAMINOGATAN 1 P.O. BOX 14 MOLNDAL SE-43121 SW SE-43121


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2013-06-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.